A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.

18 May 2017 3:34 PM | Anonymous member (Administrator)

Recently published in JAD, https://www.ncbi.nlm.nih.gov/pubmed/28453471

Powered by Wild Apricot Membership Software